Post-myocardial Infarction

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2021-11-26
Clinical Trial Update: Open-label Extension Study for CLCZ696G2301 (PARADISE-MI) [Phase 3]
Open-label extension study for CLCZ696G2301 (PARADISE-MI) has been withdrawn, affecting post-myocardial infarction population.